APRI-话题@MedSci

#APRI#

22篇内容 | 1622人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2040187, encodeId=ff8b204018e77, content=<a href='/topic/show?id=f25a2691f9' target=_blank style='color:#2F92EE;'>#APRI#</a>, objectTitle=Nat Med：Avapritinib在晚期系统性肥大细胞增多症治疗中的安全性和疗效, objectType=article, longId=221678, objectId=c95b2216e828, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c95b2216e828, replyNumber=0, likeNumber=90, createdTime=2022-10-06, rootId=0, userName=hbwxf, userId=55ce62, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c95b2216e828, moduleTitle=Nat Med：Avapritinib在晚期系统性肥大细胞增多症治疗中的安全性和疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c95b2216e828)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040186, encodeId=cb142040186f2, content=<a href='/topic/show?id=f25a2691f9' target=_blank style='color:#2F92EE;'>#APRI#</a>, objectTitle=Capricor准备将杜氏肌营养不良症 (DMD) 疗法CAP-1002推进到III期临床, objectType=article, longId=217668, objectId=1fca21e668fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1fca21e668fc, replyNumber=0, likeNumber=131, createdTime=2021-11-04, rootId=0, userName=hbwxf, userId=55ce62, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1fca21e668fc, moduleTitle=Capricor准备将杜氏肌营养不良症 (DMD) 疗法CAP-1002推进到III期临床, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1fca21e668fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040188, encodeId=b88c2040188bf, content=<a href='/topic/show?id=f25a2691f9' target=_blank style='color:#2F92EE;'>#APRI#</a>, objectTitle=Nat Med：晚期系统性肥大细胞增多症患者Avapritinib治疗的安全性和疗效, objectType=article, longId=221681, objectId=c0b722168126, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0b722168126, replyNumber=0, likeNumber=89, createdTime=2022-04-24, rootId=0, userName=hbwxf, userId=55ce62, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0b722168126, moduleTitle=Nat Med：晚期系统性肥大细胞增多症患者Avapritinib治疗的安全性和疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0b722168126)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040185, encodeId=b4772040185c7, content=<a href='/topic/show?id=f25a2691f9' target=_blank style='color:#2F92EE;'>#APRI#</a>, objectTitle=J Clin Oncol：Avapritinib对比瑞戈非尼（Regorafenib）治疗局部进展不可切除或转移性胃肠道间质瘤的疗效：随机III期研究, objectType=article, longId=215316, objectId=4736215316ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4736215316ea, replyNumber=0, likeNumber=115, createdTime=2022-01-20, rootId=0, userName=hbwxf, userId=55ce62, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4736215316ea, moduleTitle=J Clin Oncol：Avapritinib对比瑞戈非尼（Regorafenib）治疗局部进展不可切除或转移性胃肠道间质瘤的疗效：随机III期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4736215316ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040183, encodeId=09022040183ef, content=<a href='/topic/show?id=f25a2691f9' target=_blank style='color:#2F92EE;'>#APRI#</a>, objectTitle=Agendia的MammaPrint®检测在NSABP B-42试验中率先展示出预测延长内分泌治疗所带来收益的能力, objectType=article, longId=212571, objectId=42fb2125e188, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=42fb2125e188, replyNumber=0, likeNumber=88, createdTime=2021-10-30, rootId=0, userName=hbwxf, userId=55ce62, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42fb2125e188, moduleTitle=Agendia的MammaPrint®检测在NSABP B-42试验中率先展示出预测延长内分泌治疗所带来收益的能力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=42fb2125e188)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040184, encodeId=84aa204018401, content=<a href='/topic/show?id=f25a2691f9' target=_blank style='color:#2F92EE;'>#APRI#</a>, objectTitle=Agendia在ASCO 2021上呈报创新性FLEX研究的数据，展示MammaPrint和BluePrint对广大类别患者群体的效用, objectType=article, longId=212564, objectId=6f2921256483, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f2921256483, replyNumber=0, likeNumber=101, createdTime=2021-07-19, rootId=0, userName=hbwxf, userId=55ce62, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f2921256483, moduleTitle=Agendia在ASCO 2021上呈报创新性FLEX研究的数据，展示MammaPrint和BluePrint对广大类别患者群体的效用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f2921256483)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040182, encodeId=eafd2040182c1, content=<a href='/topic/show?id=f25a2691f9' target=_blank style='color:#2F92EE;'>#APRI#</a>, objectTitle=曹晖教授：Avapritinib力克耐药突变，GIST患者治疗迈向新高度, objectType=article, longId=196135, objectId=1ddd196135a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ddd196135a4, replyNumber=0, likeNumber=91, createdTime=2020-09-27, rootId=0, userName=hbwxf, userId=55ce62, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ddd196135a4, moduleTitle=曹晖教授：Avapritinib力克耐药突变，GIST患者治疗迈向新高度, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1ddd196135a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040180, encodeId=9368204018081, content=<a href='/topic/show?id=f25a2691f9' target=_blank style='color:#2F92EE;'>#APRI#</a>, objectTitle=在弓形虫病药物Daraprim价格上涨5000%后，FDA批准了其仿制药上市, objectType=article, longId=189494, objectId=e7f118949412, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e7f118949412, replyNumber=0, likeNumber=0, createdTime=2020-06-28, rootId=0, userName=hbwxf, userId=55ce62, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e7f118949412, moduleTitle=在弓形虫病药物Daraprim价格上涨5000%后，FDA批准了其仿制药上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e7f118949412)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040181, encodeId=907920401817c, content=<a href='/topic/show?id=f25a2691f9' target=_blank style='color:#2F92EE;'>#APRI#</a>, objectTitle=PDGFRα靶向新药avapritinib在中国台湾申请用于治疗晚期胃肠道间质瘤成人患者, objectType=article, longId=191054, objectId=22d01910546b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=22d01910546b, replyNumber=0, likeNumber=86, createdTime=2020-06-15, rootId=0, userName=hbwxf, userId=55ce62, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=22d01910546b, moduleTitle=PDGFRα靶向新药avapritinib在中国台湾申请用于治疗晚期胃肠道间质瘤成人患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=22d01910546b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040179, encodeId=5e6120401e920, content=<a href='/topic/show?id=f25a2691f9' target=_blank style='color:#2F92EE;'>#APRI#</a>, objectTitle=Iclaprim不会在ABSSSI患者中引起高钾血症, objectType=article, longId=180593, objectId=b5f9180593b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5f9180593b8, replyNumber=0, likeNumber=79, createdTime=2020-03-08, rootId=0, userName=hbwxf, userId=55ce62, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5f9180593b8, moduleTitle=Iclaprim不会在ABSSSI患者中引起高钾血症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5f9180593b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040177, encodeId=650320401e7f7, content=<a href='/topic/show?id=f25a2691f9' target=_blank style='color:#2F92EE;'>#APRI#</a>, objectTitle=Capricor的新型细胞疗法显着改善了Duchenne肌营养不良症患者的骨骼和心肌功能, objectType=article, longId=159122, objectId=6519159122ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6519159122ab, replyNumber=0, likeNumber=91, createdTime=2019-04-26, rootId=0, userName=hbwxf, userId=55ce62, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6519159122ab, moduleTitle=Capricor的新型细胞疗法显着改善了Duchenne肌营养不良症患者的骨骼和心肌功能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6519159122ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040178, encodeId=460e20401e872, content=<a href='/topic/show?id=f25a2691f9' target=_blank style='color:#2F92EE;'>#APRI#</a>, objectTitle=Lancet Gastroen Hepatol：APRI以及FIB-4检测法用于无创肝硬化检查的临床意义, objectType=article, longId=163926, objectId=050316392640, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=050316392640, replyNumber=0, likeNumber=85, createdTime=2019-11-29, rootId=0, userName=hbwxf, userId=55ce62, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=050316392640, moduleTitle=Lancet Gastroen Hepatol：APRI以及FIB-4检测法用于无创肝硬化检查的临床意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=050316392640)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040172, encodeId=fbdc20401e21e, content=<a href='/topic/show?id=f25a2691f9' target=_blank style='color:#2F92EE;'>#APRI#</a>, objectTitle=J Viral Hepat：相比APRI和FIB-4，GPR在预测CHB患者肝纤维化不同程度方面表现更佳, objectType=article, longId=137952, objectId=fa0613e952f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa0613e952f4, replyNumber=0, likeNumber=88, createdTime=2018-07-10, rootId=0, userName=hbwxf, userId=55ce62, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa0613e952f4, moduleTitle=J Viral Hepat：相比APRI和FIB-4，GPR在预测CHB患者肝纤维化不同程度方面表现更佳, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa0613e952f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040176, encodeId=13db20401e6e9, content=<a href='/topic/show?id=f25a2691f9' target=_blank style='color:#2F92EE;'>#APRI#</a>, objectTitle=CLIN CANCER RES：Avapritinib治疗胃肠道间质瘤, objectType=article, longId=159079, objectId=d1181590e960, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d1181590e960, replyNumber=0, likeNumber=102, createdTime=2019-08-13, rootId=0, userName=hbwxf, userId=55ce62, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1181590e960, moduleTitle=CLIN CANCER RES：Avapritinib治疗胃肠道间质瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d1181590e960)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040174, encodeId=d03e20401e42c, content=<a href='/topic/show?id=f25a2691f9' target=_blank style='color:#2F92EE;'>#APRI#</a>, objectTitle=Hepatology：miRNA- seq鉴定了一个血清miRNA，结合APRI可以检测和监测存在囊性纤维化中的儿童肝病, objectType=article, longId=145518, objectId=68991455189a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=68991455189a, replyNumber=0, likeNumber=87, createdTime=2019-06-01, rootId=0, userName=hbwxf, userId=55ce62, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=68991455189a, moduleTitle=Hepatology：miRNA- seq鉴定了一个血清miRNA，结合APRI可以检测和监测存在囊性纤维化中的儿童肝病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=68991455189a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040173, encodeId=4a3020401e364, content=<a href='/topic/show?id=f25a2691f9' target=_blank style='color:#2F92EE;'>#APRI#</a>, objectTitle=Am J Gastroenterol：非侵入性标记(ALBI和APRI)可预测慢性肝病妇女的妊娠结局, objectType=article, longId=145288, objectId=8e3b14528878, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e3b14528878, replyNumber=0, likeNumber=104, createdTime=2018-10-16, rootId=0, userName=hbwxf, userId=55ce62, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e3b14528878, moduleTitle=Am J Gastroenterol：非侵入性标记(ALBI和APRI)可预测慢性肝病妇女的妊娠结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8e3b14528878)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040175, encodeId=0b1d20401e587, content=<a href='/topic/show?id=f25a2691f9' target=_blank style='color:#2F92EE;'>#APRI#</a>, objectTitle=Motif Bio的新型抗生素iclaprim获得美国优先审查, objectType=article, longId=146657, objectId=966d14665ef3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=966d14665ef3, replyNumber=0, likeNumber=75, createdTime=2019-02-04, rootId=0, userName=hbwxf, userId=55ce62, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=966d14665ef3, moduleTitle=Motif Bio的新型抗生素iclaprim获得美国优先审查, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=966d14665ef3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040171, encodeId=024820401e121, content=<a href='/topic/show?id=f25a2691f9' target=_blank style='color:#2F92EE;'>#APRI#</a>, objectTitle=Am J Gastroenterol：非生化应答和APRI是熊去氧胆酸治疗原发性胆管炎后产生并发症的独立预测因素, objectType=article, longId=127741, objectId=464a12e74139, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=464a12e74139, replyNumber=0, likeNumber=147, createdTime=2018-09-17, rootId=0, userName=hbwxf, userId=55ce62, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=464a12e74139, moduleTitle=Am J Gastroenterol：非生化应答和APRI是熊去氧胆酸治疗原发性胆管炎后产生并发症的独立预测因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=464a12e74139)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040170, encodeId=776b20401e086, content=<a href='/topic/show?id=f25a2691f9' target=_blank style='color:#2F92EE;'>#APRI#</a>, objectTitle=Blood：APRIL，BCMA和TACI双抗原靶向的嵌合型抗原受体，在多发性骨髓瘤中的应用前景。, objectType=article, longId=125160, objectId=e657125160d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e657125160d8, replyNumber=0, likeNumber=88, createdTime=2018-09-11, rootId=0, userName=hbwxf, userId=55ce62, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e657125160d8, moduleTitle=Blood：APRIL，BCMA和TACI双抗原靶向的嵌合型抗原受体，在多发性骨髓瘤中的应用前景。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e657125160d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040169, encodeId=686d2040169fa, content=<a href='/topic/show?id=f25a2691f9' target=_blank style='color:#2F92EE;'>#APRI#</a>, objectTitle=J Viral Hepat ：GPR预测HBeAg阳性和阴性患者肝纤维化程度方面，优于APRI和FIB-4这两个指标, objectType=article, longId=123371, objectId=027f1233e1b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=027f1233e1b9, replyNumber=0, likeNumber=113, createdTime=2018-05-23, rootId=0, userName=hbwxf, userId=55ce62, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=027f1233e1b9, moduleTitle=J Viral Hepat ：GPR预测HBeAg阳性和阴性患者肝纤维化程度方面，优于APRI和FIB-4这两个指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=027f1233e1b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

APRI

2020-05-29

hbwxf (审核中...)

前往app查看评论内容

#APRI#

Nat Med：Avapritinib在晚期系统性肥大细胞增多症治疗中的安全性和疗效

2022-10-06

hbwxf (审核中...)

前往app查看评论内容

#APRI#

Capricor准备将杜氏肌营养不良症 (DMD) 疗法CAP-1002推进到III期临床

2021-11-04

hbwxf (审核中...)

前往app查看评论内容

#APRI#

Nat Med：晚期系统性肥大细胞增多症患者Avapritinib治疗的安全性和疗效

2022-04-24

hbwxf (审核中...)

前往app查看评论内容

#APRI#

J Clin Oncol：Avapritinib对比瑞戈非尼（Regorafenib）治疗局部进展不可切除或转移性胃肠道间质瘤的疗效：随机III期研究

2022-01-20

hbwxf (审核中...)

前往app查看评论内容

#APRI#

Agendia的MammaPrint®检测在NSABP B-42试验中率先展示出预测延长内分泌治疗所带来收益的能力

2021-10-30

hbwxf (审核中...)

前往app查看评论内容

#APRI#

Agendia在ASCO 2021上呈报创新性FLEX研究的数据，展示MammaPrint和BluePrint对广大类别患者群体的效用

2021-07-19

hbwxf (审核中...)

前往app查看评论内容

#APRI#

曹晖教授：Avapritinib力克耐药突变，GIST患者治疗迈向新高度

2020-09-27

hbwxf (审核中...)

前往app查看评论内容

#APRI#

在弓形虫病药物Daraprim价格上涨5000%后，FDA批准了其仿制药上市

2020-06-28

hbwxf (审核中...)

前往app查看评论内容

#APRI#

PDGFRα靶向新药avapritinib在中国台湾申请用于治疗晚期胃肠道间质瘤成人患者

2020-06-15

hbwxf (审核中...)

前往app查看评论内容

#APRI#

Iclaprim不会在ABSSSI患者中引起高钾血症

2020-03-08

hbwxf (审核中...)

前往app查看评论内容

#APRI#

Capricor的新型细胞疗法显着改善了Duchenne肌营养不良症患者的骨骼和心肌功能

2019-04-26

hbwxf (审核中...)

前往app查看评论内容

#APRI#

Lancet Gastroen Hepatol：APRI以及FIB-4检测法用于无创肝硬化检查的临床意义

2019-11-29

hbwxf (审核中...)

前往app查看评论内容

#APRI#

J Viral Hepat：相比APRI和FIB-4，GPR在预测CHB患者肝纤维化不同程度方面表现更佳

2018-07-10

hbwxf (审核中...)

前往app查看评论内容

#APRI#

CLIN CANCER RES：Avapritinib治疗胃肠道间质瘤

2019-08-13

hbwxf (审核中...)

前往app查看评论内容

#APRI#

Hepatology：miRNA- seq鉴定了一个血清miRNA，结合APRI可以检测和监测存在囊性纤维化中的儿童肝病

2019-06-01

hbwxf (审核中...)

前往app查看评论内容

#APRI#

Am J Gastroenterol：非侵入性标记(ALBI和APRI)可预测慢性肝病妇女的妊娠结局

2018-10-16

hbwxf (审核中...)

前往app查看评论内容

#APRI#

Motif Bio的新型抗生素iclaprim获得美国优先审查

2019-02-04

hbwxf (审核中...)

前往app查看评论内容

#APRI#

Am J Gastroenterol：非生化应答和APRI是熊去氧胆酸治疗原发性胆管炎后产生并发症的独立预测因素

2018-09-17

hbwxf (审核中...)

前往app查看评论内容

#APRI#

Blood：APRIL，BCMA和TACI双抗原靶向的嵌合型抗原受体，在多发性骨髓瘤中的应用前景。

2018-09-11

hbwxf (审核中...)

前往app查看评论内容

#APRI#

J Viral Hepat ：GPR预测HBeAg阳性和阴性患者肝纤维化程度方面，优于APRI和FIB-4这两个指标

2018-05-23

科室
- - 订阅+
  - 更多科室
工具
服务